MPS Limited Q1 FY27 Results: PAT Surges 43% to ₹50.39 Crore

BY ADMIN • FILED 29 Jul 2026, 5:53 PM

MPS Limited has released the transcript of its Q1 FY27 earnings conference call, highlighting the strongest first-quarter performance in the company’s history. The learning and platform solutions provider delivered robust revenue growth, significant margin expansion, and record profitability, driven by strong operating leverage and disciplined cost management.

Management also reaffirmed its positive outlook for FY27, supported by increasing adoption of AI-enabled solutions, outcome-based engagements, and a healthy balance sheet.

Q1 FY27 Financial Highlights

MPS reported strong growth across all major financial parameters during the quarter ended June 30, 2026.

Consolidated Revenue: Increased 20.4% year-on-year (YoY) to ₹224.24 crore.
EBITDA: Rose 53.0% YoY to ₹76.96 crore.
EBITDA Margin: Expanded by 730 basis points to 34.3%, compared with 27.0% in Q1 FY26.
Profit After Tax (PAT): Grew 43.0% YoY to ₹50.39 crore.
Earnings Per Share (EPS): Reached a record ₹29.70, compared with ₹20.78 in the corresponding quarter last year.

The results demonstrate the company’s ability to convert revenue growth into higher profitability through improved operational efficiency.

Strong Performance in the Core Business

Excluding the acquired eXhale business, MPS continued to deliver healthy organic growth.

Underlying Revenue: Increased 28.4% YoY to ₹198.47 crore.
Underlying EBITDA: Grew 50.5% YoY.
Underlying EBITDA Margin: Improved to 32.4%.

The performance reflects sustained demand across the company’s research, education, and corporate learning solutions.

Operating Leverage Drives Margin Expansion

One of the key highlights of the quarter was MPS’ strong operating leverage.

Despite reporting more than 20% revenue growth, the company increased its overall workforce by less than 3%, allowing a significant portion of incremental revenue to translate directly into higher operating profit.

This disciplined approach to cost management contributed to the substantial improvement in EBITDA margins and overall profitability.

Healthy Balance Sheet

MPS continued to maintain a strong financial position at the end of the quarter.

As of June 30, 2026, the company reported:

Cash and Cash Equivalents: ₹138.02 crore
Total Borrowings: ₹37.63 crore

Management noted that the outstanding debt primarily relates to financing for the Unbound Medicine acquisition, while the company’s healthy cash reserves provide financial flexibility for future growth initiatives.

FY27 Outlook

Management expressed confidence in the company’s growth prospects for the remainder of FY27.

The company expects continued momentum driven by:

Expansion of outcome-based revenue models.
Deeper integration of Artificial Intelligence across products and services.
Growing demand for digital learning, research, and education solutions.
Continued focus on operational efficiency and scalable growth.

MPS also remains committed to strengthening its technology platforms while enhancing value for customers through AI-powered innovation.